0000899243-19-007996.txt : 20190315
0000899243-19-007996.hdr.sgml : 20190315
20190315175018
ACCESSION NUMBER: 0000899243-19-007996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170622
FILED AS OF DATE: 20190315
DATE AS OF CHANGE: 20190315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KONINKLIJKE PHILIPS NV
CENTRAL INDEX KEY: 0000313216
STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37406
FILM NUMBER: 19686197
BUSINESS ADDRESS:
STREET 1: BREITNER CENTER
STREET 2: AMSTELPLEIN 2
CITY: AMSTERDAM
STATE: P7
ZIP: 1096 BC
BUSINESS PHONE: 31 20 59 77777
MAIL ADDRESS:
STREET 1: BREITNER CENTER
STREET 2: AMSTELPLEIN 2
CITY: AMSTERDAM
STATE: P7
ZIP: 1096 BC
FORMER NAME:
FORMER CONFORMED NAME: KONINKLIJKE PHILIPS ELECTRONICS NV
DATE OF NAME CHANGE: 19981217
FORMER NAME:
FORMER CONFORMED NAME: PHILIPS ELECTRONICS N V
DATE OF NAME CHANGE: 19930727
FORMER NAME:
FORMER CONFORMED NAME: PHILIPS NV
DATE OF NAME CHANGE: 19910903
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc.
CENTRAL INDEX KEY: 0001528557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 300687898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 508-653-3335
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS ROAD
STREET 2: SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: Your Internet Defender, Inc
DATE OF NAME CHANGE: 20110824
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-22
0
0001528557
Corindus Vascular Robotics, Inc.
CVRS
0000313216
KONINKLIJKE PHILIPS NV
PHILIPS CENTER, AMSTELPLEIN 2, 1096 BC
AMSTERDAM
P7
NETHERLANDS
1
0
1
0
Common Stock, par value $0.0001 per share
2017-12-15
4
A
0
9174
0.00
A
26368032
I
See footnote
Common Stock, par value $0.0001 per share
2018-05-31
4
A
0
53326
0.7501
A
26421358
I
See footnote
Non-qualified stock option (right to buy)
1.68
2017-06-22
4
A
0
17857
0.00
A
2027-06-21
Common Stock
17857
17857
I
See footnote
The common stock represents shares issuable upon vesting of restricted stock units ("RSUs") granted to Nathan Harrington in his capacity as a director of Corindus Vascular Robotics, Inc. (the "Issuer") as part of his 2017 annual equity award. The RSUs were initially vested with respect to one quarter of the granted units. The RSUs provide for vesting in quarterly installments on December 22, 2017, March 22, 2018 and June 22, 2018, subject to Mr. Harrington's continuous service with the Issuer.
These securities are held directly by Nathan Harrington, an employee of the reporting person, as compensation for his service as a director of the Issuer. Pursuant to Mr. Harrington's arrangement with the reporting person as his employer, any compensation received by Mr. Harrington during his service as a director of the Issuer is for the benefit of the reporting person and, as such, Mr. Harrington intends to transfer his securities to the reporting person for no consideration.
The common stock represents shares issuable upon vesting of RSUs granted to Mr. Harrington in his capacity as a director of the Issuer as part of his 2018 annual equity award. The RSUs provide for vesting in quarterly installments on August 31, 2018, November 30, 2018, February 28, 2019 and May 31, 2019, subject to Mr. Harrington's continuous service with the Issuer through each such vesting date.
Includes 9,174 shares of common stock related to RSUs granted as part of Mr. Harrington's 2017 annual equity award which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to Mr. Harrington's continuous service with Issuer through each such vesting date
The underlying shares vest over a period of three years with 33.33% vesting on the first anniversary of the issuance date and 8.334% vesting at the end of each calendar quarter thereafter.
Mr. Harrington is an employee of the reporting person and serves as a director of the Issuer. As a result, the reporting person may be deemed a director by deputization for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
/s/ Abhijit Bhattacharya, Chief Financial Officer
2019-03-15
/s/ Marnix van Ginneken, Chief Legal Officer
2019-03-15